Alembic Pharma FY24 net rises 80% | - Times of India

Source: The Times of India

Ahmedabad: Alembic Pharmaceuticals Limited reported an 80% year-on-year increase in its net profit at Rs 616 crore in FY24. While its net sales rose 10% to Rs 6,229 crore, EBITDA surged 41% to Rs 961 crore. Its India branded business achieved 3% growth, generating a topline of Rs 503 crore. The US Generics segment experienced a 19% growth. "The rise in profit can be attributed to several factors, including the recovery of US market, supplying new dosage forms for existing products, new product launches in the injectables, ophthalmic and dermatology segments, along with a better supply chain management," said Pranav Amin, MD, Alembic Pharmaceuticals.tnn